Skip to content

Effects of exercise on Pompe disease

A pilot study to investigate the effect of aerobic exercise training in adults with Pompe disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN53453484
Enrollment
16
Registered
2015-09-30
Start date
2015-09-16
Completion date
Unknown
Last updated
2019-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Topic: Metabolic and endocrine disorders, Musculoskeletal disorders

Interventions

Exercise, Cycling during Hospital based infusion. Participants will complete the initial, 3 month and final assessments and exercise testing at designated specialist centers in the UK.

Sponsors

UCLH NHS Trust
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged between 16 and 70 years 2. Genetically proven diagnosis of late-onset Pompe disease 3. Attending Lysosome Centres in England 4. Can complete >50m in 6 minute walk test 5. Can transfer safely and independently on and off cycle ergometer 6. Can participate in all objective testing 7. Willing and able to attend specialist treatment centres 8. Willing to receive exercise testing and supervision in their own home

Exclusion criteria

Exclusion criteria: 1. Have been receiving Enzyme Replacement Therapy for less than 12 months 2. Able to walk more then 550m 3. Dependent on invasive ventilation during the day 4. Have cardiac issues for which exercise would not be recommended 5. Any current or previous orthopaedic medical condition for which exercise is contraindicated

Design outcomes

Primary

MeasureTime frame
Walking ability measured using a 6 minute walk test (6MWT) which will be recorded at baseline, 3 months and 6 months.

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026